A state of innate and adaptive immunity in children with schizophrenia and in the high-risk group for the disease

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 105, Issue 11, 2005, Pages 45-49

  Shcherbakova, I V ^a   Kozlovskaya, G V ^a   Kalinina, M A ^a   Klyushnik, T P ^a  

^a NONE

Author keywords

Childhood schizophrenia; High risk groups; Psychoneuroimmunology

Indexed keywords

ALPHA 1 ANTITRYPSIN; AUTOANTIBODY; C REACTIVE PROTEIN; LEUKOCYTE ELASTASE; NERVE GROWTH FACTOR;

ARTICLE; ENZYMOLOGY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; METABOLISM; PRESCHOOL CHILD; RISK FACTOR; SCHIZOPHRENIA;

ALPHA 1-ANTITRYPSIN; AUTOANTIBODIES; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LEUKOCYTE ELASTASE; MALE; NERVE GROWTH FACTOR; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 33644832969     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Armao D., Kornfeld M., Estrada F.Y. et al. Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res 1997; 767: 2: 259-264.
2. Black S., Kushner I., Samols D. C-reactive Protein. J Biol Chem 2004; 279: 47: 48487-48490.
3. Bolognesi M., Djinovic-Carugo K., Ascenzi P. Molecular bases for human leukocyte inhibition. Mondaldi Arch Chest Dis 1994; 49: 2: 144-149.
4. Fearon D. T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 5258: 50-53.
5. Ho B.C., Andreasen N.C., Nopoulos P. et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiat 2003; 60: 6: 585-594.
6. Hoebe K., Janssen E., Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004; 5: 10: 971-974.
7. Jankovic B., Djordjijevic D. Differential appearance of autoantibodies to human brain S-100 protein, neuron specific enolase and myelin basic protein in psychiatric patients. Int J Neurosci 1991; 60: 119-127.
8. Kirch D.G. Infection and autoimmunity as etiologic factor in schizophrenia: a review and reappraisal. Schizophr Bull 1993; 19: 2: 355-370.
9. Mania-Pramanik J., Potdar S.S., Vadigoppula A., Sawant S. Elastase: a predictive marker of inflammation and or infection. J Clin Lab Anal 2004; 18: 3: 153-158.
10. Molina V., Sanz J., Reig S. et al. Hypofrontality in men with first-episode psychosis. Br J Psychiat 2005; 186: 203-208.
11. Nagy Z., Kolev K., Csonka E. et al. Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes. Blood Coagul Fibrinolysis 1998; 9: 6: 471-478.
12. 2-macroglobulin and α-antichimotrypsin. In: Neutral protease of human polymorphonuclear leukocytes. 1973; 167-176.
13. Shimakura A., Kamanaka Y., Ikeda Y. et al. Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion. Brain Res 2000; 6: 858: I: 55-60.
14. Torzewski M., Torzewski M., Rist C. et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Atheroscler Thromb Vasc Biol 2000; 20: 2094-2099.
15. Travis J., Salvesen G. Human plasma proteinase inhibitors. Ann Rev Biochem 1983; 52: 655-709.
16. Wright I.C., Rabe-Hesketh S., Woodruff P.W. et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiat 2000; 157: 1: 16-25.